Living definition
What is Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Test?
Medical Imaging & DiagnosticsBio, Health & Neuro
- As of
- 2026-10-01
- Revision
- 2026-10-06.1
- Method
- v1.4.0
Definition
The term, in context
AI-assisted draft · approved dataset
The Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Test is a blood-based diagnostic assay that measures the ratio of phosphorylated tau 217 protein to amyloid-beta 42 protein in a patient's blood plasma using automated immunoassay chemistry, providing a less invasive alternative to PET scans or cerebrospinal fluid testing for detecting amyloid pathology associated with Alzheimer's disease.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-10-01, verified readiness is 45 (claimed 55, reported 45, gap 10) — Strong evidence strength; current signals suggest Consider controlled specialist use with requalified reagents and continuing quality monitoring.
The readiness fact belongs to the canonical Readiness Verdict for Fujirebio Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio Test.
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06